Specialty Pharmacy

Top news of the day from across the health care landscape.

A look at last week's top stories in the world of pharmacy.

The study emphasizes the need for harm reduction interventions that include access to syringes and sterile injection equipment, in addition to comprehensive HIV prevention services.

How changes related to Brexit may influence regulatory, research, and economic perspectives, as well as human health.

The massive online retailer is entering the online pharmacy world with its acquisition of PillPack.

Patients with melanoma who were treated with a combination of radiosurgery and anti-PD-1 immunotherapy experienced better outcomes compared with patients who received anti-CTLA4 immunotherapy.

Top news of the day from across the health care landscape

REMOXY ER is an abuse-deterrent, oral formulation of the widely prescribed opioid medication oxycodone.

Encorafenib (Braftovi) and binimetinib (Mektovi) is now available for patients with advanced BRAF-mutant melanoma.

Researchers identified a trend in which higher body mass index was associated with lower breast cancer risk in women before menopause.

Although HIV diagnoses have dropped across every population in the United States, African Americans remain disproportionately affected by HIV.

Top news of the day from across the health care landscape

Mortality from opioids may be higher than it appears.

National HIV Testing Day, designated by the CDC, aims to encourage individuals to know their status.

New data demonstrate that evolocumab (Repatha) significantly reduced low-density lipoprotein cholesterol and non-high density lipoprotein cholesterol in patients with type 2 diabetes plus hypercholesterolemia or mixed dyslipidemia.

A novel epigenetic drug can be combined with an existing therapy, venetoclax, to more effectively kill high-risk neuroblastoma cells.

Top news of the day from across the health care landscape

Elotuzumab with pomalidomide and low-dose dexamethasone met its primary endpoint in showing a statistically significant, clinically meaningful improvement in progression-free survival in patients with relapsed/refractory multiple myeloma.

Officials with the FDA have approved plazomicin (Zemdri, Achaogen) for the treatment of adults with complicated urinary tract infections (cUTIs), caused by certain Enterobacteriaceae, in patients with limited or no alternative treatment.

Epidiolex is the first FDA-approved drug that contains an active ingredient derived from marijuana and is the first approved treatment for patients with Dravet syndrome.

Current definitions attempting to summarize specialty pharmacy fall short.

The findings highlight the role of Epstein-Barr virus (EBV) infection in multiple sclerosis pathogenesis and support therapies targeting EBV-infected immune cells.

Top news of the day from across the health care landscape

Many individuals at high risk of getting HIV—including those who inject drugs, gay and bisexual men, and partners of people with HIV—are not screened annually and experience delays in diagnosis.

Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses developments for ACHC in the pharmacy accreditation space.

A look at last week's top stories in the world of pharmacy.

Top news of the week from Specialty Pharmacy Times.

New data show an association between potentially inappropriate prescribing practices and higher risk of all-cause mortality, and both fatal and non-fatal overdose.

Top news of the day from across the health care landscape

Nivolumab plus low-dose ipilimumab demonstrated positive initial results in part 1 of a phase 3 study.